ALPN

Alpine Immune Sciences, Inc. Common Stock
ALPN

Overview Fund Activity
Delisted

ALPN was delisted on the 17th of May, 2024.

Back to rankings

63 hedge funds and large institutions have $251M invested in Alpine Immune Sciences, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 33 increasing their positions, 9 reducing their positions, and 15 closing their positions.

Holders
63
Holders Change
-7
Holders Change %
-10%
% of All Funds
1.02%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.05%
New
8
Increased
33
Reduced
9
Closed
15
Calls
$8K
Puts
$1K
Net Calls
+$7K
Net Calls Change
+$8K

Top Buyers

1
BlackRock
1
BlackRock
New York
$10.6M
2
Vanguard Group
2
Vanguard Group
Pennsylvania
$10M
3
Geode Capital Management
3
Geode Capital Management
Massachusetts
$3.57M
4
GPP
4
Great Point Partners
Connecticut
$26.7M
5
CCMU
5
Cheyne Capital Management (UK)
United Kingdom
$1.34M

Top Sellers

1
DCMIC
1
Decheng Capital Management III (Cayman)
Cayman Islands
$0
2
Allspring Global Investments
2
Allspring Global Investments
North Carolina
$32.7K
3
MIM
3
Monashee Investment Management
Massachusetts
$0
4
Walleye Capital
4
Walleye Capital
New York
$0
5
BCM
5
Bridgeway Capital Management
Texas
$0
Name Market Value Shares Shares
Change 		Shares
Change %
Simplex Trading
76
Simplex Trading
Illinois
– – -129 Closed
Wells Fargo
77
Wells Fargo
California
– – -127 Closed
CFGS
78
Concourse Financial Group Securities
Alabama
– – – –
Nisa Investment Advisors
79
Nisa Investment Advisors
Missouri
$0 12 +12 New
1 2 3
4